EDGAR Filing Documents for 0001193125-20-005823

Form 8-K - Current report:

SEC Accession No. 0001193125-20-005823

Filing Date

2020-01-13

Accepted

2020-01-13 06:19:36

Documents

Period of Report

2020-01-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d866341d8k.htm	8-K	30334
2	EX-10.1	d866341dex101.htm	EX-10.1	101875
3	EX-10.2	d866341dex102.htm	EX-10.2	110524
4	EX-10.3	d866341dex103.htm	EX-10.3	32730
	Complete submission text file	0001193125-20-005823.txt		276935

Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747

Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416

KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)